Crizanlizumab and sickle cell disease: When should medications have their approval status revoked?

Affiliations

• ¹ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
• ² Department of Pathology, University of California San Diego, La Jolla, California, USA.
• ³ Ethics Consultation Service & Pulmonary & Critical Care Medicine Section, Veterans Affairs Loma Linda Healthcare System, Loma Linda, California, USA.
• ⁴ Division of Pulmonary and Critical Care Medicine, Department of Medicine, Loma Linda University School of Medicine, Loma Linda, California, USA.
• ⁵ Division of Transfusion Medicine, Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
• ⁶ Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
• ⁷ Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.